Kari Lislerud
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Immunotherapy and Immune Responses 6
- Oncology 6
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Gustav Gaudernack (7 shared papers)Jon Amund Kyte (4 shared papers)Gunnar Kvalheim (4 shared papers)Sissel Trachsel (2 shared papers)Steinar Aamdal (3 shared papers)Svein Dueland (2 shared papers)Jens Bjørheim (1 shared paper)Ingvil Sæterdal (1 shared paper)
- Journals
- OncoImmunology (2 papers)Cancer Immunology Immunotherapy (2 papers)Journal of Immunological Methods (1 paper)Cancer Gene Therapy (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- NorwayUnited KingdomDenmark
In The Last Decade
Kari Lislerud
7 papers receiving 631 citations
Peers
Comparison fields: 5 of 49
- Immunology 390
- Oncology 329
- Pathology and Forensic Medicine 107
- Biotechnology 30
- Cancer Research 47
Countries citing papers authored by Kari Lislerud
This map shows the geographic impact of Kari Lislerud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Lislerud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Lislerud more than expected).
Fields of papers citing papers by Kari Lislerud
This network shows the impact of papers produced by Kari Lislerud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Lislerud. The network helps show where Kari Lislerud may publish in the future.
Co-authors
The 24 scholars most cited alongside Kari Lislerud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 232 | |
| 2 | 2006 | 174 | |
| 3 | 2012 | 91 | |
| 4 | 2006 | 50 | |
| 5 | 2009 | 47 | |
| 6 | 2010 | 40 | |
| 7 | 2016 | 18 |
About Kari Lislerud
Kari Lislerud is a scholar working on Immunology, Oncology, Pathology and Forensic Medicine, Molecular Biology and Genetics, having authored 7 papers that have together received 652 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), vaccines and immunoinformatics approaches (2 papers), RNA Interference and Gene Delivery (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Virus-based gene therapy research (1 paper) and Genetic factors in colorectal cancer (1 paper). The work is most often cited by research in Immunology (390 citations), Oncology (329 citations), Pathology and Forensic Medicine (107 citations), Biotechnology (30 citations) and Cancer Research (47 citations). Kari Lislerud has collaborated with scholars based in Norway, United Kingdom and Denmark. Frequent co-authors include Gustav Gaudernack, Jon Amund Kyte, Gunnar Kvalheim, Sissel Trachsel, Steinar Aamdal, Svein Dueland, Jens Bjørheim, Ingvil Sæterdal, Jahn Martin Nesland and Marianne Klemp. Their work appears in journals such as OncoImmunology, Cancer Immunology Immunotherapy, Journal of Immunological Methods, Cancer Gene Therapy and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.